Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
5
×
life sciences
national blog main
national top stories
san diego blog main
san diego top stories
san francisco blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alirocumab
amgen
drugs
fda
regeneron pharmaceuticals
startups
alder biopharmaceutical
alex azar
allergan
american academy of neurology
american patients first
artificial intelligence
atogepant
What
drug
5
×
drugs
5
×
new
cost
advance
afternoon
algorithms
anticipated
approval
arguments
awaited
batch
big
biologic
biology
biotech
blueprint
bottlenecks
called
cholesterol
class
clinical
combinator’s
commercialized
companies
competitors
cut
cytokine
decades
demonstrating
details
developing
development
diego’s
dollars
enhanced
expensive
faces
fda
financial
Language
unset
Current search:
biotech
×
drug
×
drugs
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks